Home Featured Surprise billing legal limbo & device price persuasion

Surprise billing legal limbo & device price persuasion

0
Surprise billing legal limbo & device price persuasion


You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow of money through the health care system. Sign up here to get it in your inbox.

A different way for physicians to get recertified

Doctors dislike renewing their specialty certifications, also known as “maintenance of certification” in industry jargon. They say the traditional boards they have to go through require irrelevant tests, have too many hoops, and are too expensive. But a new competitor is gaining a lot of traction, Tara reports.

The National Board of Physicians and Surgeons has the backing of some prominent doctors like Eric Topol, costs at least half as much as mainstream boards, and runs a lean operation. Instead of mandating tests, it requires doctors to complete continuing medical education and other activities to prove they still know their stuff. Importantly, the group cleared a significant milestone in July, when the Joint Commission said NBPAS is qualified to verify credentials.

advertisement

The next big step for NBPAS is persuading more hospitals to accept its recertification for medical staff. Just 157 hospitals have done that so far, and many of the prestigious academic hospitals aren’t keen on joining. Read Tara’s story, which provides more details about NBPAS and explains why a major incumbent board still has an upper hand.

Device makers ‘don’t go in asking for less money’

Medicare is expected to pay more than $86 billion next year for care given in hospital outpatient clinics and surgery centers, and certain niches of the industry are hoping to shovel more of that money toward their devices and services.

advertisement

Medical device executives, lobbyists, and physicians made pitches to Medicare officials and independent experts last week during a meeting held by what’s known as the Advisory Panel on Hospital Outpatient Payment. They were hoping to persuade the federal agency to dole out higher payments for numerous types of devices and services, ranging from drugs that get inserted into the eye to hernia repairs.

Read the story, which highlights presentations that came from companies and people who had undisclosed conflicts of interests or revolving-door relationships.

Crickets on surprise billing lawsuits

Now that the federal government has laid out how doctors, hospitals, insurers, and other health care players should proceed in the surprise billing law’s arbitration process, the most pressing next step is determining what happens to all those lawsuits that hinge on that updated process.

So far, mum’s the word. STAT reached out to the plaintiffs of all eight pending lawsuits. None elaborated what their next steps would be, despite months of lobbying and, presumably, internal planning of what they would do based on the final rule. The closest thing to a development: A meeting took place in court last Thursday in the lawsuit led by the Association of Air Medical Services, and the parties in that case scheduled another meeting Sept. 21.

Chris Eastlee, a lobbyist with AAMS, said the group has “made no decisions on the lawsuit” and is “still analyzing the rule and its impact.” The American Medical Association, which filed a joint lawsuit with the American Hospital Association in December, also said it is still reviewing the rule, and “we’ll need to hold off on comments until the review is complete.” The AHA did not respond. The American College of Emergency Physicians said it still has “some concerns” and is evaluating “the merits of moving forward.” The remaining plaintiffs either did not respond or said they are still determining what to do.

One thing is clear amid the legal limbo: The process has been a free-for-all so far, and there’s no assurances the final rule will make it any better in the near term. In just four months, between April 15 and Aug. 11, providers and insurers initiated more than 46,000 disputes — “substantially more” than the government thought there would be in an entire year, according to a federal update released last week. Arbiters have resolved just 1,200, or 3%, of the disputes. Job security is looking good for medical dispute reviewers and consultants.

OIG vs. Cigna

If you’re in the mood to read a gripping, bureaucratic throwdown, this one’s for you: The watchdogs at the HHS Office of Inspector General last week released a 75-page audit report of a Medicare Advantage plan owned by Cigna. OIG looked at an older sample of members in one of Cigna’s MA contracts and concluded Cigna has to repay $39,612 for overcoding problems in that sample.

It’s a paltry amount for Cigna — a rounding error on a rounding error. But the report is a window into how controversial MA coding is and how contentious these types of audits are. There’s also a very notable nugget buried on page 62: OIG originally ordered Cigna to repay $10 million because the agency extrapolated the overpayments from its sample across the entire contract.

Cigna fired back, particularly against the use of extrapolation, and OIG ultimately laid off. OIG said it relented not because Cigna whined about the extrapolation, but because “Cigna applied additional information” for some of the unvalidated medical codes, which were then validated.

It’s worth noting Cigna has a very checkered history within Medicare Advantage. The government suspended Cigna’s MA enrollment in 2016 after finding a slew of “long-standing” problems, like inappropriately denying care and drugs to its members. More recently, this past February and March, CMS slapped Cigna with two separate fines, totaling $200,000, because its MA plans charged some patients the wrong coinsurance amounts and, again, inappropriately denied care.

Industry odds and ends

  • My colleague Damian Garde just published a compelling profile of Stelios Papadopoulos, the “Godfather of Biotech” and board chair of the troubled drug company Biogen. Make sure to stay for the anecdote of when Papadopoulos “had to dispose of a body stashed in a trunk.”
  • Moderna sued Pfizer and BioNTech over Covid-19 vaccine patents, my colleague Jason Mast reports. The biggest winners likely will be intellectual property attorneys who get to milk years of billable hours.
  • Tara and I have been chatting about the rush of Q2 financial filings from tax-exempt hospital systems, and they continue to vary quite a bit. On the one hand, you have UPMC, the behemoth hospital, doctor, and health insurance network in Pittsburgh, which seems like the perfect microcosm of health care right now: Its insurance division’s finances improved in the first half of 2022 while the provider division got worse. But on the other hand, you have Orlando Health, which registered an operating margin above 10% — double from the same time in 2021.
  • In June, Bon Secours Mercy Health bought Nordic Consulting Group, a health and tech consulting firm. We now know the price tag: $394 million. Another expansion out of care for the sprawling Catholic hospital system.
  • The latest Bill of the Month from Kaiser Health News/NPR is a classic, merciless tale of high prices and deductibles combining to make a patient miserable: A hospital owned by HCA charged $18,000 for a breast biopsy; Cigna “negotiated” that down to $8,400; and the patient was stuck with more than $5,000 of that total. The hospital later offered an arbitrary 36% discount, meaning the patient still dumped more than $3,300 onto a credit card.

The Meme Ward

(Yep, it’s happening.)